Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
39
# OF OVERLAPPING
HOLDINGS
XBI
139
HOLDINGS
29%
ALSO IN WDNA
WDNA
85
HOLDINGS
49%
ALSO IN XBI
SECTOR DRIFT (XBI minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
AMICUS THERAPEUTICS INC | 1.5% | 2.2% | 1.5% |
|
MODERNA, INC. | 1.4% | 2.6% | 1.4% |
|
KRYSTAL BIOTECH, INC. | 1.3% | 1.5% | 1.3% |
|
VERTEX PHARMACEUTICALS INC | 1.3% | 1.4% | 1.3% |
 |
ROIVANT SCIENCES LTD. | 1.3% | 1.3% | 1.3% |
XBI Overweight Relative to WDNA
|
INCYTE CORP | 1.4% |
|
MIRUM PHARMACEUTICALS, INC. | 1.3% |
|
REVOLUTION MEDICINES, INC. | 1.3% |
|
VAXCYTE, INC. | 1.3% |
|
CELCUITY INC. | 1.3% |
|
PTC THERAPEUTICS INC | 1.3% |
 |
ALKERMES PLC | 1.3% |
|
CYTOKINETICS INC | 1.3% |
|
AVIDITY BIOSCIENCES INC | 1.2% |
|
TRAVERE THERAPEUTICS, INC. | 1.2% |
XBI Underweight Relative to WDNA
|
ELI LILLY & CO | -3.1% |
|
JOHNSON & JOHNSON | -2.7% |
|
PFIZER INC | -2.4% |
 |
BIONTECH SE SPONSORED ADR | -2.3% |
 |
NOVO NORDISK A/S-B | -2.2% |
|
ASTRAZENECA PLC-SPONS ADR | -2.1% |
|
REGENXBIO, INC. | -2.1% |
|
NOVOZYMES A/S-B SHARES | -2.0% |
|
STOKE THERAPEUTICS, INC. | -1.9% |
|
NATERA INC | -1.7% |